---
title: "DRI Healthcare exercises put option on EKTERLY royalty stake for net US$178 million"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292327315.md"
description: "DRI Healthcare Trust exercised a put option to sell its royalty stake in EKTERLY (sebetralstat) for approximately USD 178 million. This transaction is linked to Chiesi Group's acquisition of KalVista Pharmaceuticals, completed on June 11, 2026. Payment is expected by mid-August, subject to the terms of the royalty agreement."
datetime: "2026-07-10T13:29:36.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292327315.md)
  - [en](https://longbridge.com/en/news/292327315.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292327315.md)
generator: "portal-rs"
---

# DRI Healthcare exercises put option on EKTERLY royalty stake for net US$178 million

-   DRI Healthcare Trust exercised a put option to sell its royalty participation right in EKTERLY (sebetralstat) for about USD 178 million. \* The repurchase is tied to Chiesi Group’s acquisition of KalVista Pharmaceuticals, completed June 11, 2026. \* Payment is expected no later than mid-August, subject to the royalty agreement terms. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DRI Healthcare Trust published the original content used to generate this news brief on July 10, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [KALV.US](https://longbridge.com/en/quote/KALV.US.md)

## Related News & Research

- [DRI Healthcare receives put price of about US$178 million for EKTERLY royalty interest](https://longbridge.com/en/news/295535642.md)
- [Full Transcript: DRI HEALTHCARE TRUST Q1 2026 Earnings Call](https://longbridge.com/en/news/286578500.md)
- [Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?](https://longbridge.com/en/news/296682368.md)
- [Darden Restaurants, Inc. (NYSE:DRI) Receives Consensus Rating of "Moderate Buy" from Brokerages](https://longbridge.com/en/news/296743710.md)
- [DLaboratory issues correction to Q2 2026 interim report release after missing MAR label](https://longbridge.com/en/news/296449167.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**